Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study.
Bussini L, Rosselli Del Turco E, Pasquini Z, Scolz K, Amedeo A, Beci G, Giglia M, Tedeschi S, Pascale R, Ambretti S, Pericàs JM, Giannella M, Carvalho-Brugger S, Gutiérrez L, Viale P, Bartoletti M. Bussini L, et al. Among authors: pericas jm. J Glob Antimicrob Resist. 2022 Jun;29:386-389. doi: 10.1016/j.jgar.2022.05.003. Epub 2022 May 13. J Glob Antimicrob Resist. 2022. PMID: 35569757 Free article.
Clinical utility of daptomycin in infective endocarditis caused by Gram-positive cocci.
Cervera C, Castañeda X, Pericas JM, Del Río A, de la Maria CG, Mestres C, Falces C, Marco F, Moreno A, Miró JM. Cervera C, et al. Among authors: pericas jm. Int J Antimicrob Agents. 2011 Nov;38(5):365-70. doi: 10.1016/j.ijantimicag.2010.11.038. Epub 2011 Mar 21. Int J Antimicrob Agents. 2011. PMID: 21420835 Review.
Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin.
García-de-la-Mària C, Pericas JM, Del Río A, Castañeda X, Vila-Farrés X, Armero Y, Espinal PA, Cervera C, Soy D, Falces C, Ninot S, Almela M, Mestres CA, Gatell JM, Vila J, Moreno A, Marco F, Miró JM; Hospital Clinic Experimental Endocarditis Study Group. García-de-la-Mària C, et al. Among authors: pericas jm. Antimicrob Agents Chemother. 2013 May;57(5):2319-25. doi: 10.1128/AAC.01921-12. Epub 2013 Mar 11. Antimicrob Agents Chemother. 2013. PMID: 23478959 Free PMC article.
A Contemporary Picture of Enterococcal Endocarditis.
Pericàs JM, Llopis J, Muñoz P, Gálvez-Acebal J, Kestler M, Valerio M, Hernández-Meneses M, Goenaga MÁ, Cobo-Belaustegui M, Montejo M, Ojeda-Burgos G, Sousa-Regueiro MD, de Alarcón A, Ramos-Martínez A, Miró JM; GAMES Investigators. Pericàs JM, et al. J Am Coll Cardiol. 2020 Feb 11;75(5):482-494. doi: 10.1016/j.jacc.2019.11.047. J Am Coll Cardiol. 2020. PMID: 32029130 Free article.
How do I manage a patient with enterococcal bacteraemia?
Rosselli Del Turco E, Bartoletti M, Dahl A, Cervera C, Pericàs JM. Rosselli Del Turco E, et al. Among authors: pericas jm. Clin Microbiol Infect. 2021 Mar;27(3):364-371. doi: 10.1016/j.cmi.2020.10.029. Epub 2020 Nov 2. Clin Microbiol Infect. 2021. PMID: 33152537 Free article. Review.
Treatment duration for central line-associated infection caused by Enterococcus spp.: a retrospective evaluation of a multicenter cohort.
Rosselli Del Turco E, Pasquini Z, Scolz K, Amedeo A, Beci G, Giglia M, Bussini L, Carvalho-Brugger S, Gutiérrez L, Tedeschi S, Garcia M, Ambretti S, Pericàs JM, Giannella M, Viale P, Bartoletti M. Rosselli Del Turco E, et al. Among authors: pericas jm. Eur J Clin Microbiol Infect Dis. 2022 Sep;41(9):1203-1206. doi: 10.1007/s10096-022-04481-w. Epub 2022 Aug 1. Eur J Clin Microbiol Infect Dis. 2022. PMID: 35915273
Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study.
Cervera C, del Río A, García L, Sala M, Almela M, Moreno A, Falces C, Mestres CA, Marco F, Robau M, Gatell JM, Miró JM; Hospital Clinic Endocarditis Study Group. Cervera C, et al. Enferm Infecc Microbiol Clin. 2011 Oct;29(8):587-92. doi: 10.1016/j.eimc.2011.05.007. Epub 2011 Jun 30. Enferm Infecc Microbiol Clin. 2011. PMID: 21723004 Clinical Trial.
High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis.
Miró JM, Entenza JM, Del Río A, Velasco M, Castañeda X, Garcia de la Mària C, Giddey M, Armero Y, Pericàs JM, Cervera C, Mestres CA, Almela M, Falces C, Marco F, Moreillon P, Moreno A; Hospital Clinic Experimental Endocarditis Study Group. Miró JM, et al. Among authors: pericas jm. Antimicrob Agents Chemother. 2012 Aug;56(8):4511-5. doi: 10.1128/AAC.06449-11. Epub 2012 May 29. Antimicrob Agents Chemother. 2012. PMID: 22644033 Free PMC article.
Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.
Cervera C, Castañeda X, de la Maria CG, del Rio A, Moreno A, Soy D, Pericas JM, Falces C, Armero Y, Almela M, Ninot S, Pare JC, Mestres CA, Gatell JM, Marco F, Miro JM; Hospital Clinic Endocarditis Study Group. Cervera C, et al. Among authors: pericas jm. Clin Infect Dis. 2014 Jun;58(12):1668-75. doi: 10.1093/cid/ciu183. Epub 2014 Mar 18. Clin Infect Dis. 2014. PMID: 24647021
200 results